<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>19</volume><submitter>Budny V</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>The main genetic risk factor for Alzheimer's disease (AD) is the presence of the apolipoprotein E4 (&lt;i>APOE4&lt;/i>) allele. While &lt;i>APOE4&lt;/i> increases the risk of developing AD, the &lt;i>APOE2&lt;/i> allele is protective and &lt;i>APOE3&lt;/i> is risk-neutral. In the brain, APOE is primarily expressed by astrocytes and plays a key role in various processes including cholesterol and lipid transport, neuronal growth, synaptic plasticity, immune response and energy metabolism. Disruptions in brain energy metabolism are considered a major contributor to AD pathophysiology, raising a key question about how different APOE isoforms affect the energy metabolism of human astrocytes.&lt;h4>Methods&lt;/h4>In this study, we generated astrocytes (iAstrocytes) from &lt;i>APOE&lt;/i>-isogenic human induced</pubmed_abstract><journal>Frontiers in cellular neuroscience</journal><pagination>1603657</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12434100</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>APOE genotype-dependent differences in human astrocytic energy metabolism.</pubmed_title><pmcid>PMC12434100</pmcid><pubmed_authors>Barros LF</pubmed_authors><pubmed_authors>Rust R</pubmed_authors><pubmed_authors>Kruger M</pubmed_authors><pubmed_authors>Budny V</pubmed_authors><pubmed_authors>Zurcher KJ</pubmed_authors><pubmed_authors>Ruminot I</pubmed_authors><pubmed_authors>de Leeuw SM</pubmed_authors><pubmed_authors>Ravotto L</pubmed_authors><pubmed_authors>Weber RZ</pubmed_authors><pubmed_authors>Bodenmann C</pubmed_authors><pubmed_authors>Weber B</pubmed_authors><pubmed_authors>Tackenberg C</pubmed_authors></additional><is_claimable>false</is_claimable><name>APOE genotype-dependent differences in human astrocytic energy metabolism.</name><description>&lt;h4>Introduction&lt;/h4>The main genetic risk factor for Alzheimer's disease (AD) is the presence of the apolipoprotein E4 (&lt;i>APOE4&lt;/i>) allele. While &lt;i>APOE4&lt;/i> increases the risk of developing AD, the &lt;i>APOE2&lt;/i> allele is protective and &lt;i>APOE3&lt;/i> is risk-neutral. In the brain, APOE is primarily expressed by astrocytes and plays a key role in various processes including cholesterol and lipid transport, neuronal growth, synaptic plasticity, immune response and energy metabolism. Disruptions in brain energy metabolism are considered a major contributor to AD pathophysiology, raising a key question about how different APOE isoforms affect the energy metabolism of human astrocytes.&lt;h4>Methods&lt;/h4>In this study, we generated astrocytes (iAstrocytes) from &lt;i>APOE&lt;/i>-isogenic human induced</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-06-02T05:25:51.03Z</modification><creation>2026-04-14T03:13:59.808Z</creation></dates><accession>S-EPMC12434100</accession><cross_references><pubmed>40958776</pubmed><doi>10.3389/fncel.2025.1603657</doi></cross_references></HashMap>